跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
FUROSEMIDA PENSA 40 MG COMPRIMIDOS EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
FUROSEMIDA PENSA 40 MG COMPRIMIDOS EFG
Approved
STANDARD
FUROSEMIDA PENSA 40 MG COMPRIMIDOS EFG
Towa Pharmaceutical S.A.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Feb 25, 2021
Approval ID
b715a0d02c5679c3
Company
Towa Pharmaceutical S.A.
Type
Standard
Approval Details
Approval Id
b715a0d02c5679c3
Drug Cima Aemps Name
FUROSEMIDA PENSA 40 MG COMPRIMIDOS EFG
Register Number
85813
Holder Company Name
Towa Pharmaceutical S.A.
Marketing Company Name
Towa Pharmaceutical S.A.
Authorization Date
2021-02-25
Dosage Form
COMPRIMIDO
Dose
40 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica. Tratamiento De Larga Duración
Commercialized
Yes
Company Name
Towa Pharmaceutical S.A.
Active Ingredients
FUROSEMIDA
40 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Feb 25, 2021
Approval ID
b715a0d02c5679c3
Type
Standard
Back to CIMA-AEMPS Approvals